Reviews of registry data indicate that patients with VHL-associated RCC have a higher primary tumor size threshold for metastatic disease, a significantly higher overall survival (12), and an increased cancer-specific survival when compared to patients with similarly sized sporadic RCC (13). The gene discussed is VHL; the disease is cancer.